Brevetoxin PbTx 1 - CAS 98112-41-5
Not Intended for Therapeutic Use. For research use only.
Category:
ADCs
Product Name:
Brevetoxin PbTx 1
Catalog Number:
98112-41-5
CAS Number:
98112-41-5
Description:
An activator of voltage-sensitive Na+ channels, a suite of cyclic polyether compounds produced naturally by a species of dinoflagellate known as Karenia brevis. A ciguatoxin comprising a linear sequence of ten trans-fused five-, six-, eight- and nine-membered rings.
Molecular Weight:
867.08
Molecular Formula:
C49H70O13
COA:
Inquire
MSDS:
Inquire
Tag:
ADCs Cytotoxin
Chemical Structure
CAS 98112-41-5 Brevetoxin PbTx 1

Related ADCs Cytotoxin Products


CAS 93438-65-4 Conantokin-G

Conantokin-G
(CAS: 93438-65-4)

Conantokin-G is a conopeptide that has been isolated from the venom of the cone Conus geographus. Conantokin-G selectively inhibits NR2B containing N-methyl-D-a...

Q Pr

Synthetic, nicotinic AChR. Rigid bicyclic analog of TMA and TEA.

FSP-3

Anticoagulant: irreversible inhibits serine proteinase a-thrombine. Fluorocontaining phosphonate, synthetised.

CAS 2752-64-9 Mesaconitine

Mesaconitine
(CAS: 2752-64-9)

Mesaconitine has antinociceptive activity through cyclic AMP and stimulation of the central β-adrenergic system.

Ungerine Nitrate

Alkaloid , from plants of the Ungernia genus, Amaryllidaceae.

CAS 515-25-3 Betonicine

Betonicine
(CAS: 515-25-3)

Is any neutral chemical compound with a positively charged cationic functional group such as a quaternary ammonium or phosphonium cation which bears no hydrogen...

CAS 134710-25-1 Calciseptine

Calciseptine
(CAS: 134710-25-1)

Calciseptine is a natural neurotoxin isolated from the black mamba Dendroaspis p. polylepis venom. This toxin consists of 60 amino acids with four disulfide bon...

CAS 20830-81-3 Daunorubicin

Daunorubicin
(CAS: 20830-81-3)

Daunorubicin(RP13057) inhibits both DNA and RNA synthesis and inhibits DNA synthesis with Ki of 0.02 μM.

CAS 18172-33-3 Cyclopiazonic Acid

Cyclopiazonic Acid
(CAS: 18172-33-3)

Cyclopiazonic acid is a mycotoxin produced by molds including certain species of Penicillium and Aspergillus. Its toxicity is linked to its ability to specifica...

CAS 12778-32-4 β-Bungarotoxin

β-Bungarotoxin
(CAS: 12778-32-4)

β-Bungarotoxin is a form of bungarotoxin that is fairly common in Krait (Bungaros multicinctus) venoms. A pre-synaptic toxin with enzymatic activity.

DM4
(CAS: 796073-69-3)

DM 4 is an intermediate used to prepare semisynthetic maytansine analogs which can be conjugated with antibodies for the targeted treatment of cancer.

CAS 10180-88-8 Austricine

Austricine
(CAS: 10180-88-8)

A hypolipidemic, antiatherosclerotic, anti-inflammatory agent, with angioprotective and hepatoprotective activity; antiulcerous. Sesquiterpene lactone , from pl...

CAS 61989-75-1 Imperialone

Imperialone
(CAS: 61989-75-1)

Steroidal Alkaloid Derivative of Imperialine extracted from Petilium eduardi, a medium-lasting and selective M2 muscarinic receptors antagonist.

CAS 522-11-2 Evoxine

Evoxine
(CAS: 522-11-2)

Evoxine (haploperine) is a furoquinoline alkaloid with hypnotic and sedative effects. It is found naturally in a variety of Australian and African plants includ...

Flodiphoside
(CAS: 142450-99-5)

organophosphoric inhibitor, SA-​152, on the fibrinogen-​coagulating and TAME-​esterase activity of bovine α-​thrombin.

CAS 7082-34-0 Erysimoside

Erysimoside
(CAS: 7082-34-0)

Na+,K+-ATPase inhibiting activity of cardiac glycosides from Erysimum cheiranthoides

FSP-2

Anticoagulant: irreversible inhibitor of serine proteinase a-thrombine. Fluorocontaining phosphonate, synthetised.

Convolvidine
(CAS: 50656-81-0)

A native alkaloid A tropane alkaloid Extracted from Convolvulus subhirsitus plant.

CAS 39089-30-0 Karakoline

Karakoline
(CAS: 39089-30-0)

Alkaloid , from plants of the Ranunculaceae family. Ganglioblocker; nicotinic receptor antagonist; hypotensive; presents micromolar affinity at brain a Bungarot...

CAS 6681-13-6 Hernandezine

Hernandezine
(CAS: 6681-13-6)

Anti-tumor effect of hernandezine and other components extracted from Thalictrum glandulosissimum.

Reference Reading


1.Proteomic modification in gills and brains of medaka fish (Oryzias melastigma) after exposure to a sodium channel activator neurotoxin, brevetoxin-1.
Tian L1, Wang M, Li X, Lam PK, Wang M, Wang D, Chou HN, Li Y, Chan LL. Aquat Toxicol. 2011 Aug;104(3-4):211-7. doi: 10.1016/j.aquatox.2011.04.019. Epub 2011 May 6.
Although brevetoxins (PbTxs) produced by the marine dinoflagellate Karenia brevis are known to be absorbed across gill membranes and exert their acute toxic effects through an ion-channel mediated pathway in neural tissue, the exact biochemical mechanism concerning PbTxs neurotoxicity in neural tissue and gas-exchange organs has not been well elucidated. In this study, we calculated the LC(50) value of PbTx-1 using the medaka fish model, and presented the molecular responses of sub-acute exposure to PbTx-1 with proteomic method. By adopting two-dimensional electrophoresis, the abundances of 14 and 24 proteins were found to be remarkably altered in the gills and brains, respectively, in response to toxin exposure. Thirteen gill and twenty brain proteins were identified using matrix-assisted laser desorption/ionization tandem time-of-flight mass spectrometry analysis. These proteins could be categorized into diverse functional classes such as cell structure, macromolecule metabolism, signal transduction and neurotransmitter release.
2.Characterization of polar brevetoxin derivatives isolated from Karenia brevis cultures and natural blooms.
Abraham A1, Plakas SM, Wang Z, Jester EL, El Said KR, Granade HR, Henry MS, Blum PC, Pierce RH, Dickey RW. Toxicon. 2006 Jul;48(1):104-15. Epub 2006 May 6.
Several novel brevetoxin derivatives were isolated and identified in Karenia brevis cultures and natural blooms by using solid phase extraction (SPE) and LC/MS(MS) techniques. These analogs were more polar compared with previously described brevetoxins, and were poorly extractable by conventional non-polar solvent (chloroform) partitioning. Brevetoxin analogs were structurally confirmed as hydrolyzed (open A-ring) forms of brevetoxins PbTx-1, PbTx-7, PbTx-2, and PbTx-3, and of oxidized PbTx-1 and PbTx-2. Some of these open A-ring derivatives were in greater abundance than their non-hydrolyzed counterparts. All were in much greater abundance in bloom water filtrate compared with cell-rich fractions. Open A-ring compounds were cytotoxic in mouse neuroblastoma (N2a) cell assay. In the K. brevis bloom-exposed Eastern oyster, brevetoxin metabolites with opened A rings were identified (e.g., open-ring cysteine-PbTx conjugates), contributing to their overall toxin burden.
3.Brevetoxin metabolism and elimination in the Eastern oyster (Crassostrea virginica) after controlled exposures to Karenia brevis.
Plakas SM1, Wang Z, El Said KR, Jester EL, Granade HR, Flewelling L, Scott P, Dickey RW. Toxicon. 2004 Nov;44(6):677-85.
The metabolism and elimination of brevetoxins were examined in the Eastern oyster (Crassostrea virginica) following controlled exposures to Karenia brevis cultures in the laboratory. After a 2-day exposure period ( approximately 62 million cells/oyster), elimination of brevetoxins and their metabolites was monitored by using liquid chromatography/mass spectrometry (LC/MS). Composite toxin in oyster extracts was measured by in vitro assay (i.e. cytotoxicity, receptor binding, and ELISA). Of the parent algal toxins, PbTx-1 and PbTx-2 were not detectable by LC/MS in K. brevis-exposed oysters. PbTx-3 and PbTx-9, which are accumulated directly from K. brevis and through metabolic reduction of PbTx-2 in the oyster, were at levels initially (after exposure) of 0.74 and 0.49 microg equiv./g, respectively, and were eliminated largely within 2 weeks after dosing. PbTx-7 and PbTx-10, the reduced forms of PbTx-1, were non-detectable. Conjugative brevetoxin metabolites identified previously in field-exposed oysters were confirmed in the laboratory-exposed oysters.
4.LC/MS analysis of brevetoxin metabolites in the Eastern oyster (Crassostrea virginica).
Wang Z1, Plakas SM, El Said KR, Jester EL, Granade HR, Dickey RW. Toxicon. 2004 Mar 15;43(4):455-65.
Brevetoxin (PbTx) metabolism was examined in the Eastern oyster (Crassostrea virginica) following exposure to a Karenia brevis red tide, by using LC/MS(/MS) and cytotoxicity assay. Metabolites observed in field-exposed oysters were confirmed in oysters exposed to K. brevis cultures in the laboratory. Previously, we identified a cysteine conjugate and its sulfoxide (MH(+): m/z 1018 and 1034) as metabolites of the brevetoxin congener PbTx-2. In the present study, we found a cysteine conjugate and its sulfoxide with A-type brevetoxin backbone structure (MH(+): m/z 990 and 1006), as probable derivatives of PbTx-1. We also found glycine-cysteine-PbTx (m/z 1047 and 1075), gamma-glutamyl-cysteine-PbTx (m/z 1147), and glutathione-PbTx (m/z 1176 and 1204) conjugates with A- and B-type backbone structures. Amino acid-PbTx conjugates react with fatty acids through amide linkage to form a series of fatty acid-amino acid-PbTx conjugates. These fatty acid conjugates are major contributors to the composite cytototoxic responses obtained in extracts of brevetoxin-contaminated oysters.